
Home » FDA Clears nContact’s Cardiac Ablation Device
FDA Clears nContact’s Cardiac Ablation Device
nContact announced that the FDA has cleared the company’s modifications to its VisiTrax cardiac ablation device, EPi-Sense, now with embedded sensing capability.
BusinessWire
BusinessWire
Upcoming Events
-
10Aug
-
08Sep
-
15Sep
-
20Sep
-
21Sep
-
22Sep